ENGN (enGene Holdings Inc.) Short-Term Debt to Capital
This GURU.Markets price chart for enGene Holdings Inc. (ENGN) reflects a debt-to-equity ratio of 0.00. The firm's technological advantage is secured by patents for mucosal drug delivery methods. The business model relies on developing non-viral, unconventional therapies for bladder cancer, while human capital is sustained by attracting leading immunologists through a long-term incentive system.
Analytical breakdowns for enGene Holdings Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:enGene Bio
Developing a unique non-viral gene delivery platform requires significant investment in R&D and FDA certification. Analyzing the short-term debt-to-market cap chart, an investor assesses the proportion of current liabilities relative to the company's equity. This metric measures the business's dependence on rapid refinancing and the risk of liquidity loss. The stability of this ratio confirms the financial resilience of enGene Holdings Inc. (ENGN) within the highly competitive biopharmaceutical sector.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Current Liabilities to Capital Septerna Pharma|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio SVRA|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|ANAB - Short-Term Indebtedness to Equity|Short-Term Debt to Capital ATXS|RAPT - Current Liabilities to Capital|Short-Term Debt to Equity Aerovate Therapeutics JBIO|ACRS: Short-Term Debt to Capital Ratio|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - Short-Term Debt to Equity Ratio|Ventyx Biosciences, Inc - Ratio of Short-Term Indebtedness to Capital|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|AVTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Current Liabilities to Capital|Short-Term Debt to Equity Climb Bio, Inc. CLYM|zurabio.com - Short-Term Debt to Equity|aTyr Pharma, Inc. - Short-Term Debt to Capital|ADAG (Adagene) - Short-Term Debt to Capital Ratio|IMA: Short-Term Debt to Capital|STTK - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Equillium Inc|Short-Term Debt to Capital Ratio CNTB (Connect Pharma)|Short-Term Debt to Capital IMUX|atarabio.com (ATRA) - Short-Term Indebtedness to Equity|Short-Term Debt to Equity InflaRx IFRX|Short-Term Debt to Capital Coefficient X4 Pharmaceuticals Inc. (XFOR)|ACET: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital CELU (Celularity Inc.)|INMB: Short-Term Debt to Capital|BRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Kezar Life Sciences, Inc.|Short-Term Debt to Capital Ratio SABS (SAB Biotherapeutics Inc.)|Short-Term Debt to Capital AKTX|Short-Term Debt to Equity Ratio enlivex.com ENLV|Q32 Bio - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient geovax.com (GOVX)|Edesa Biotech - Short-Term Debt to Capital|Current Liabilities to Capital iBio Inc|carismatx.com (CARM) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio XTLB|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|HCWB - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Aptevo Therapeutics (APVO)|aimimmuno.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Current Liabilities to Equity|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|Short-Term Debt to Equity Scinai|CALI: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TCBP: Short-Term Debt to Capital|THRD - Short-Term Debt to Capital Coefficient